The Healthcare Distribution Management Association (HDMA), an industry association for US wholesalers and distributors, honored Eisai with its 2015 Distribution Industry Award for Notable Achievement in Healthcare (DIANA) Award for “Partner of the Year” with sales to U.S. wholesalers of over 500 million.
This follows the DIANA award Eisai’s BELVIQ® (lorcaserin HCI) CIV Tablets won at the 2014 event for “Best New Product Introduction of the Year” in the Branded Pharmaceutical Products category.
Given annually since 1959, HDMA’s DIANA is awarded to pharmaceutical and consumer product manufacturers that set the standard of excellence in new product introductions, product promotions and business practices among their healthcare distributors.
The Teens 4 Pink program, which is sponsored by Eisai, won two awards at competitions celebrating public relations excellence in 2015.
The program won a Big Apple Award in Multicultural Public Relations: Government Associations and Non-Profit Organizations Category at the 2015 Big Apple Awards Gala in late May. The Big Apple Awards are selected from programs created by public relations professionals in New York, New Jersey and Connecticut. Teens 4 Pink also won the Silver Anvil Award, which is given out annually to organizations reaching the very highest levels of professional achievement in public relations.
Teens 4 Pink was created by the Sisters Network Inc. to empower African American teenagers to talk to their family members about breast health. The program highlights the importance of annual check-ups and early detection by reaching one family, one household at a time. Pilot programs have been launched in Houston, TX and Memphis, TN. So far, over 1,000 teens have been trained as Teens 4 Pink ambassadors.
The Sisters Network Inc., which was founded in 1994 by breast cancer survivor Karen E. Jackson, is a leading voice and the only national African American breast cancer survivorship organization in the United States. The organization currently has 3,000 members, and consists of more than 40 survivor-run affiliate chapters nationwide.
Eisai was listed in the top 10 global reputable drugmakers in the annual polling conducted by PatientView, a research firm, which surveyed 1,150 patient groups in 58 countries. Rankings were based on integrity; transparency; providing needed information; emphasizing product safety and selling needed drugs.
Eisai was ranked 11th among the world’s leading pharmaceutical companies in the Access to Medicine Index (ATM Index) 2014, which independently evaluates companies' efforts to improve access to medicine (ATM) in developing countries.
The ATM Foundation, which is funded by Bill & Melinda Gates Foundation, U.K. and Dutch governments, is an independent not-for-profit organization dedicated to addressing the challenges of access to medicine worldwide. Based in the Netherlands, the Foundation has published the Access to Medicine Index every two years since 2008.
Eisai increased four places from its previous ranking in 2012, and was the highest ranked of the four Japanese pharmaceutical companies evaluated. During the two-year ranking period, Eisai committed to the elimination of lymphatic filariasis, a neglected tropical disease (NTD), by providing diethylcarbamazine citrate (DEC) tablets to the World Health Organization (WHO).
Eisai received the Cardinal Health FY2014 Supply Chain Excellence Award at the Cardinal Health Business Partners Conference in Columbus, Ohio, marking the 10th year in a row the company has received the honor.
The award is given to manufacturers who demonstrate their excellence by focusing on improved communications and operational efficiencies throughout the supply chain.
For the second consecutive year, General Counsel Allen Waxman was named a finalist for the 2015 NJBIZ General Counsel of the Year Award in the private company with revenues over $500 million category. Waxman, who joined Eisai in 2012, was one of seven finalists in the category. The awards program honors New Jersey’s standout general counsels, chief legal officers and corporate compliance professionals for the critical role they play in making their companies successful.
Eisai was selected as a finalist for the 2014 NJBIZ Business of the Year Award in the “100+ employees” category. NJBIZ is New Jersey’s only weekly business journal that covers the entire state and celebrates its most dynamic businesses and business leaders. As a finalist, the company was featured in a special NJBIZ supplement that highlighted the organization.
Eisai took home two awards at the sixth annual PM360 2014 Trailblazer Awards, which recognizes outstanding achievement and innovation in healthcare marketing.
The company won the Gold PM360 Trailblazer Initiative Award for the Payer Access Program category for BELVIQ® (lorcaserin HCI) CIV Tablets. The healthcare professional website for BELVIQ®, BELVIQhcp.com, was also selected as a Silver Award winner.
Eisai was named Manufacturer of the Year in the Brand and Specialty Pharmaceuticals category at the 2014 H.D. Smith Trading Partner of the Year award event held in Charleston, S.C.
The awards are selected based on several criteria, including overall trade policies; product line profitability within the business segment; contribution to sales growth through product line sales and marketing plans; and participation in annual marketing programs and events. Finalists are nominated by category management, with three finalists designated for each product category and volume designation.
Eisai’s Legal Department was named the “Litigation Team of the Year” at the 2014 Global Counsel Awards ceremony, which is sponsored by the International Law Office in association with the Association of Corporate Counsel. Eisai’s team, which bested five other companies to win the award, was nominated for the award by one of its outside counsel.
Global Safety Assessment Officer and Vice President of International Product Safety Ilona Surick was selected as one of New Jersey’s Best 50 Women in Business in 2014 by NJBIZ magazine. An 18-year veteran of Eisai, Surick received the honor based on her community involvement and significant contributions to Eisai’s business, including leading the U.S. Product Safety department and the Proactive Safety Surveillance Program, as well as serving as the company’s global safety assessment officer.
Eisai’s “Troublesome Trio” campaign for AcipHex® (rabeprazole sodium) Delayed-Release Tablets, which utilizes a group of three animated characters, won two awards at the Art Directors Club of New Jersey 50th Annual Award Show. The AcipHex Augmented Reality App won the Silver Award, while the AcipHex “Savings Steal the Show” Lenticular Leave Behind won the Bronze Award.
Competing against 60 of the largest, branded drug manufacturers in the country, Eisai was selected as AmerisourceBergen’s “Manufacturer of the Year” in the Branded Pharmaceutical Sales over $500 million category at its 2013 ThinkLive Manufacturer Summit. Senior Director of Trade Relations Sean Spears was honored with the “Outstanding Leadership in Trade Relations” award, becoming the first Eisai employee to win an award from AmerisourceBergen.
Eisai won the Large Brand Rx Manufacturer of the Year award from McKesson, the world’s largest wholesale drug distributor, besting a field of big pharma competitors who each conduct more than $500 million in annual sales with McKesson.
“Eisai continues to search for new ways to partner with McKesson, and they have built key relationships across the company,” said Ted Boyle, McKesson’s Vice President and General Manager of Plasma Biologics and Brand Program Management, as he presented the award.
Eisai’s Magnolia Meals at Home® program won the Platinum Award in the “Corporate Social Responsibility” category in the 2013 Hermes Creative Awards competition, an international competition for creative professionals involved in the concept, writing and design of traditional and emerging media.
The Magnolia Meals at Home program won two 2013 MarCom Awards, including a Platinum Award for its PR Program and a Gold Award for Media Placement for a Boston Globe story that ran on September 19. The MarCom Awards are a competition for any individual or company involved in the concept, writing and design of print, visual, audio and web materials and programs. Approximately 6,000 entries are submitted each year in the MarCom competition.
The Magnolia Meals at Home program was a Bronze Anvil Award of Commendation Winner at the 2013 Public Relations Society of America (PRSA) Bronze Anvil Awards, which celebrate the “best of the best” in public relations tactics.
The Magnolia Meals at Home program also won a Big Apple Award in “Public Service: Business” category at the 2013 Big Apple Awards Gala, which honors programs created by public relations professionals in New York, New Jersey and Connecticut.